Citi lowered the firm’s price target on RXO Inc. (RXO) to $15 from $23 and keeps a Neutral rating on the shares. Transports were already ...

Nyxoah Provides Update on FDA Approvable Letter for Genio System Expects to meet final FDA requirements for full PMA approval in the second ...